Diabetes: clinical trials and information
Diabetes clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Connected Healthcare for Individuals Living at Home With Chronic Conditions NCT04339296 | Completed | Not applicable | Alberta | Alberta Health Services, Calgary | 2019-03-01 |
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec NCT02789800 | Completed | Not applicable | Quebec | Université de Sherbrooke | 2016-04-22 |
| Patient-Centred Innovations for Persons With Multimorbidity - Ontario NCT02742597 | Completed | Not applicable | Ontario | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-12 |
| Detecting and Addressing Preclinical Disability NCT01979081 | Completed | Ontario | McMaster University | 2013-01 | |
| I Am Able: Population Based Rehabilitation in a Family Health Team NCT00859638 | Completed | Not applicable | Ontario | Hamilton Health Sciences Corporation | 2008-05 |
Diabetes clinical trials worldwide (outside Canada)
18 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma NCT05561595 | Active, not recruiting | Not applicable | United States | University of Florida | 2024-10-03 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy NCT06071975 | Unknown status | Phase 3 | Germany | Apurano Pharmaceuticals GmbH | 2023-11-02 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy NCT06072573 | Unknown status | Phase 3 | Germany | Apurano Pharmaceuticals GmbH | 2023-11-02 |
| The Living With a Long-Term Condition Study NCT06072287 | Unknown status | United Kingdom | King's College London | 2023-06-28 | |
| Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain NCT06064058 | Completed | Not applicable | Iraq | University of Baghdad | 2023-01-30 |
| Risk Factors, Costs, and Impacts of ED Boarding NCT07532564 | Completed | United States | University of Maryland, Baltimore | 2022-01-01 | |
| Quest to Analyze One Thousand Humans Meditating NCT06583395 | Enrolling by invitation | United States | Tobias Moeller-Bertram | 2021-12-05 | |
| Arts & Health Education to Improve Health, Resilience, and Well-Being NCT04154579 | Terminated | Not applicable | United States | Lisa Gallagher | 2019-07-01 |
| Developing Enhanced Prediction Models NCT02983812 | Completed | United States | University of Pennsylvania | 2017-01-23 | |
| iCBT for Long-term Conditions in IAPT NCT03068286 | Terminated | Not applicable | United Kingdom | Derek Richards | 2017-01-01 |
| Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems NCT02868983 | Unknown status | Not applicable | United States | University of Vermont | 2016-04 |
| Patient and Provider Assessment of Lipid Management Registry NCT02341664 | Completed | United States | Duke University | 2015-05 | |
| PatientSpot Formerly Known as ArthritisPower NCT03840928 | Unknown status | United States | Global Healthy Living Foundation | 2015-04-01 | |
| Molecular Mediators of Nerve Injury Signaling NCT01437332 | Unknown status | Israel | Rambam Health Care Campus | 2011-09 | |
| Cancer in Patients With Gabapentin (GPRD) NCT01236053 | Completed | GlaxoSmithKline | 2010-06 | ||
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) NCT01138124 | Completed | GlaxoSmithKline | 2010-03 | ||
| Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program NCT01599143 | Completed | Phase 1 | North York General Hospital | 2009-01 | |
| Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component) NCT03221127 | Active, not recruiting | University of Eastern Finland | 1984-03-01 |
About Diabetes
What is Diabetes?
"Diabetes" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 23 chronic pain registry records worldwide.
How is Diabetes usually assessed?
Assessment of chronic pain generally involves a clinician taking a detailed history, a physical examination and, where relevant, tests to look for underlying causes. Pain rating scales and questionnaires about function, sleep and mood are often used. The approach depends on the person and the condition.
What kinds of treatments are studied for Diabetes?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Diabetes clinical trials in Canada?
This page lists 5 registry records for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.